应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
IBRX ImmunityBio, Inc.
已收盘 11-05 16:00:00 EST
5.44
+0.24
+4.62%
盘后
5.43
-0.01
-0.18%
19:52 EST
最高
5.54
最低
5.00
成交量
500.41万
今开
5.11
昨收
5.20
日振幅
10.38%
总市值
37.89亿
流通市值
9.00亿
总股本
6.97亿
成交额
2,684万
换手率
3.02%
流通股本
1.65亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Immunitybio, Inc.盘中异动 早盘急速下挫5.87%报4.97美元
市场透视 · 11-04 22:52
Immunitybio, Inc.盘中异动 早盘急速下挫5.87%报4.97美元
Immunitybio, Inc.盘中异动 快速跳水5.17%报5.32美元
市场透视 · 10-30
Immunitybio, Inc.盘中异动 快速跳水5.17%报5.32美元
Immunitybio, Inc.盘中异动 早盘快速下跌5.02%
市场透视 · 10-29
Immunitybio, Inc.盘中异动 早盘快速下跌5.02%
Immunitybio, Inc.盘中异动 快速拉升7.89%
市场透视 · 10-28
Immunitybio, Inc.盘中异动 快速拉升7.89%
Immunitybio, Inc.盘中异动 早盘股价大涨15.07%
市场透视 · 10-25
Immunitybio, Inc.盘中异动 早盘股价大涨15.07%
Immunitybio, Inc.盘中异动 早盘快速上涨5.78%报3.66美元
市场透视 · 10-24
Immunitybio, Inc.盘中异动 早盘快速上涨5.78%报3.66美元
Immunitybio, Inc.盘中异动 早盘急速上涨5.87%
市场透视 · 10-23
Immunitybio, Inc.盘中异动 早盘急速上涨5.87%
Immunitybio, Inc.盘中异动 下午盘急速下跌5.26%
市场透视 · 10-18
Immunitybio, Inc.盘中异动 下午盘急速下跌5.26%
Immunitybio, Inc.盘中异动 早盘股价大跌5.11%
市场透视 · 10-09
Immunitybio, Inc.盘中异动 早盘股价大跌5.11%
Immunitybio, Inc.盘中异动 下午盘急速下挫5.04%报3.39美元
市场透视 · 10-04
Immunitybio, Inc.盘中异动 下午盘急速下挫5.04%报3.39美元
Immunitybio, Inc.盘中异动 下午盘股价大跌5.09%报3.73美元
市场透视 · 10-01
Immunitybio, Inc.盘中异动 下午盘股价大跌5.09%报3.73美元
Immunitybio, Inc.盘中异动 下午盘股价大涨5.23%报3.62美元
市场透视 · 09-25
Immunitybio, Inc.盘中异动 下午盘股价大涨5.23%报3.62美元
异动解读 | 分析师下调目标价,ImmunityBio股价大跌近6%
异动解读 · 08-19
异动解读 | 分析师下调目标价,ImmunityBio股价大跌近6%
美国研究综述-欧特克、Crowdstrike、奥什科什
Reuters · 08-19
美国研究综述-欧特克、Crowdstrike、奥什科什
Immunitybio, Inc.盘中异动 早盘股价大跌5.72%报3.55美元
自选股智能写手 · 08-14
Immunitybio, Inc.盘中异动 早盘股价大跌5.72%报3.55美元
Immunitybio, Inc.盘中异动 早盘大幅下跌6.11%
自选股智能写手 · 08-13
Immunitybio, Inc.盘中异动 早盘大幅下跌6.11%
Immunitybio, Inc.盘中异动 早盘急速拉升5.09%报4.57美元
自选股智能写手 · 08-09
Immunitybio, Inc.盘中异动 早盘急速拉升5.09%报4.57美元
Immunitybio, Inc.盘中异动 早盘大幅上涨5.05%
自选股智能写手 · 08-08
Immunitybio, Inc.盘中异动 早盘大幅上涨5.05%
Immunitybio, Inc.盘中异动 早盘快速拉升5.68%
自选股智能写手 · 08-06
Immunitybio, Inc.盘中异动 早盘快速拉升5.68%
Immunitybio, Inc.盘中异动 大幅下挫8.12%报4.30美元
自选股智能写手 · 08-05
Immunitybio, Inc.盘中异动 大幅下挫8.12%报4.30美元
加载更多
公司概况
公司名称:
ImmunityBio, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
ImmunityBio, Inc.于2002年10月7日在伊利诺伊州ZelleRx Corporation公司的名义下注册成立,于2010年1月22日,公司更名为Conkwest股份有限公司。ImmunityBio是一家领先的后期免疫疗法公司,可激活先天性(NK细胞和巨噬细胞)和适应性(T细胞)免疫系统,以治疗肿瘤学和传染病中严重的未满足需求。他们是现成的自然杀伤(NK)细胞疗法,自体/同种异体记忆NK细胞(m-ceNK)的临床剂型的领先生产商,以及抗体细胞因子融合蛋白,白蛋白结合化学疗法的全面平台免疫调节剂和疫苗载体。通过组合这些NK,巨噬细胞和T细胞活化平台,他们相信ImmunityBio引领免疫疗法领域,跨多种肿瘤类型和感染性疾病进行后期临床开发。
发行价格:
--
{"stockData":{"symbol":"IBRX","market":"US","secType":"STK","nameCN":"ImmunityBio, Inc.","latestPrice":5.44,"timestamp":1730840400000,"preClose":5.2,"halted":0,"volume":5004122,"hourTrading":{"tag":"盘后","latestPrice":5.43,"preClose":5.44,"latestTime":"19:52 EST","volume":458638,"amount":2495286.3579,"timestamp":1730854350650},"delay":0,"floatShares":165468966,"shares":696533418,"eps":-0.948753,"marketStatus":"已收盘","marketStatusCode":5,"change":0.24,"latestTime":"11-05 16:00:00 EST","open":5.11,"high":5.54,"low":5,"amount":26840966.4657108,"amplitude":0.103846,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.948753,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1730883600000},"adr":0,"listingDate":1438056000000,"adjPreClose":5.2,"preHourTrading":{"tag":"盘前","latestPrice":5.0903,"preClose":5.2,"latestTime":"09:26 EST","volume":8934,"amount":46014.0372138,"timestamp":1730816813804},"postHourTrading":{"tag":"盘后","latestPrice":5.43,"preClose":5.44,"latestTime":"19:52 EST","volume":458638,"amount":2495286.3579,"timestamp":1730854350650},"volumeRatio":0.661574,"impliedVol":1.0495,"impliedVolPercentile":0.3214},"requestUrl":"/m/hq/s/IBRX","defaultTab":"news","newsList":[{"id":"2480584721","title":"Immunitybio, Inc.盘中异动 早盘急速下挫5.87%报4.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480584721","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480584721?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:52","pubTimestamp":1730731979,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时52分,Immunitybio, Inc.股票出现波动,股价大幅下跌5.87%。截至发稿,该股报4.97美元/股,成交量52.3645万股,换手率0.08%,振幅4.55%。Immunitybio, Inc.股票所在的生物技术行业中,整体跌幅为0.02%。Immunitybio, Inc.公司简介:ImmunityBio Inc 是一家临床阶段的综合性生物技术公司,致力于发现,开发和商业化下一代免疫和细胞疗法,以增强天然免疫系统,驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104225259a215534f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104225259a215534f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":1},{"id":"2479783730","title":"Immunitybio, Inc.盘中异动 快速跳水5.17%报5.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479783730","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479783730?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:31","pubTimestamp":1730295107,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日21时31分,Immunitybio, Inc.股票出现异动,股价急速下跌5.17%。Immunitybio, Inc.股票所在的生物技术行业中,整体跌幅为0.30%。Immunitybio, Inc.公司简介:ImmunityBio Inc 是一家临床阶段的综合性生物技术公司,致力于发现,开发和商业化下一代免疫和细胞疗法,以增强天然免疫系统,驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021314798e3f65c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021314798e3f65c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX","BK4139"],"gpt_icon":1},{"id":"2479037288","title":"Immunitybio, Inc.盘中异动 早盘快速下跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479037288","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479037288?lang=zh_cn&edition=full","pubTime":"2024-10-29 21:45","pubTimestamp":1730209508,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日21时45分,Immunitybio, Inc.股票出现波动,股价快速跳水5.02%。Immunitybio, Inc.股票所在的生物技术行业中,整体跌幅为0.11%。Immunitybio, Inc.公司简介:ImmunityBio Inc 是一家临床阶段的综合性生物技术公司,致力于发现,开发和商业化下一代免疫和细胞疗法,以增强天然免疫系统,驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102921450898e3f1be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102921450898e3f1be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":1},{"id":"2478481623","title":"Immunitybio, Inc.盘中异动 快速拉升7.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478481623","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478481623?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:31","pubTimestamp":1730122281,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时31分,Immunitybio, Inc.股票出现异动,股价快速上涨7.89%。Immunitybio, Inc.股票所在的生物技术行业中,整体涨幅为0.25%。Immunitybio, Inc.公司简介:ImmunityBio Inc 是一家临床阶段的综合性生物技术公司,致力于发现,开发和商业化下一代免疫和细胞疗法,以增强天然免疫系统,驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821312195bd74f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821312195bd74f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2478933523","title":"Immunitybio, Inc.盘中异动 早盘股价大涨15.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478933523","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478933523?lang=zh_cn&edition=full","pubTime":"2024-10-25 21:31","pubTimestamp":1729863063,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日21时31分,Immunitybio, Inc.股票出现波动,股价快速上涨15.07%。Immunitybio, Inc.股票所在的生物技术行业中,整体涨幅为0.35%。Immunitybio, Inc.公司简介:ImmunityBio Inc 是一家临床阶段的综合性生物技术公司,致力于发现,开发和商业化下一代免疫和细胞疗法,以增强天然免疫系统,驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102521310395bd5899&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102521310395bd5899&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4183","ELAB","IBRX","BK4139"],"gpt_icon":0},{"id":"2477632388","title":"Immunitybio, Inc.盘中异动 早盘快速上涨5.78%报3.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477632388","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477632388?lang=zh_cn&edition=full","pubTime":"2024-10-24 21:57","pubTimestamp":1729778256,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日21时57分,Immunitybio, Inc.股票出现波动,股价大幅上涨5.78%。截至发稿,该股报3.66美元/股,成交量50.9万股,换手率0.07%,振幅5.20%。Immunitybio, Inc.股票所在的生物技术行业中,整体涨幅为0.74%。Immunitybio, Inc.公司简介:ImmunityBio Inc 是一家临床阶段的综合性生物技术公司,致力于发现,开发和商业化下一代免疫和细胞疗法,以增强天然免疫系统,驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024215736971a213c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024215736971a213c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"2477382155","title":"Immunitybio, Inc.盘中异动 早盘急速上涨5.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477382155","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477382155?lang=zh_cn&edition=full","pubTime":"2024-10-23 21:31","pubTimestamp":1729690270,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日21时31分,Immunitybio, Inc.股票出现波动,股价大幅拉升5.87%。Immunitybio, Inc.股票所在的生物技术行业中,整体跌幅为0.17%。Immunitybio, Inc.公司简介:ImmunityBio Inc 是一家临床阶段的综合性生物技术公司,致力于发现,开发和商业化下一代免疫和细胞疗法,以增强天然免疫系统,驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023213110a1e3fed3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023213110a1e3fed3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"2476486619","title":"Immunitybio, Inc.盘中异动 下午盘急速下跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476486619","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476486619?lang=zh_cn&edition=full","pubTime":"2024-10-18 01:52","pubTimestamp":1729187540,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日01时52分,Immunitybio, Inc.股票出现异动,股价急速下跌5.26%。Immunitybio, Inc.股票所在的生物技术行业中,整体涨幅为1.05%。Immunitybio, Inc.公司简介:ImmunityBio Inc 是一家临床阶段的综合性生物技术公司,致力于发现,开发和商业化下一代免疫和细胞疗法,以增强天然免疫系统,驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018015220971a0e4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018015220971a0e4c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2474222312","title":"Immunitybio, Inc.盘中异动 早盘股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474222312","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474222312?lang=zh_cn&edition=full","pubTime":"2024-10-09 22:33","pubTimestamp":1728484437,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日22时33分,Immunitybio, Inc.股票出现波动,股价大幅跳水5.11%。截至发稿,该股报3.34美元/股,成交量59.0825万股,换手率0.08%,振幅5.11%。Immunitybio, Inc.股票所在的生物技术行业中,整体跌幅为0.45%。Immunitybio, Inc.公司简介:ImmunityBio Inc 是一家临床阶段的综合性生物技术公司,致力于发现,开发和商业化下一代免疫和细胞疗法,以增强天然免疫系统,驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009223357a1df6e38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009223357a1df6e38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","BK4139","IBRX"],"gpt_icon":0},{"id":"2472990641","title":"Immunitybio, Inc.盘中异动 下午盘急速下挫5.04%报3.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472990641","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472990641?lang=zh_cn&edition=full","pubTime":"2024-10-04 01:30","pubTimestamp":1727976656,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日01时30分,Immunitybio, Inc.股票出现波动,股价快速下挫5.04%。截至发稿,该股报3.39美元/股,成交量119.272万股,换手率0.17%,振幅3.78%。Immunitybio, Inc.股票所在的生物技术行业中,整体跌幅为1.50%。Immunitybio, Inc.公司简介:ImmunityBio Inc 是一家临床阶段的综合性生物技术公司,致力于发现,开发和商业化下一代免疫和细胞疗法,以增强天然免疫系统,驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100401305698e3a749&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100401305698e3a749&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELAB","BK4183","BK4139","IBRX"],"gpt_icon":0},{"id":"2472553293","title":"Immunitybio, Inc.盘中异动 下午盘股价大跌5.09%报3.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472553293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472553293?lang=zh_cn&edition=full","pubTime":"2024-10-01 03:28","pubTimestamp":1727724513,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日03时28分,Immunitybio, Inc.股票出现异动,股价大幅跳水5.09%。截至发稿,该股报3.73美元/股,成交量163.297万股,换手率0.23%,振幅5.00%。Immunitybio, Inc.股票所在的生物技术行业中,整体涨幅为0.14%。Immunitybio, Inc.公司简介:ImmunityBio Inc 是一家临床阶段的综合性生物技术公司,致力于发现,开发和商业化下一代免疫和细胞疗法,以增强天然免疫系统,驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001032834ab67327e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001032834ab67327e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"2470644377","title":"Immunitybio, Inc.盘中异动 下午盘股价大涨5.23%报3.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470644377","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470644377?lang=zh_cn&edition=full","pubTime":"2024-09-25 02:34","pubTimestamp":1727202871,"startTime":"0","endTime":"0","summary":"北京时间2024年09月25日02时34分,Immunitybio, Inc.股票出现波动,股价急速拉升5.23%。截至发稿,该股报3.62美元/股,成交量89.2698万股,换手率0.13%,振幅6.25%。Immunitybio, Inc.股票所在的生物技术行业中,整体跌幅为1.51%。Immunitybio, Inc.公司简介:ImmunityBio Inc 是一家临床阶段的综合性生物技术公司,致力于发现,开发和商业化下一代免疫和细胞疗法,以增强天然免疫系统,驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409250234319719c703&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409250234319719c703&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"1121769960","title":"异动解读 | 分析师下调目标价,ImmunityBio股价大跌近6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1121769960","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121769960?lang=zh_cn&edition=full","pubTime":"2024-08-19 21:34","pubTimestamp":1724074456,"startTime":"0","endTime":"0","summary":"生物科技公司ImmunityBio Inc.周一在盘中大幅下跌近6%,主要原因是有分析师下调了该公司股票的目标价。\n\n分析机构Jefferies将ImmunityBio的目标价从9美元下调至8美元,而Piper Sandler则将目标价从6美元下调至4.75美元。虽然两家机构均未解释下调目标价的原因,但通常这种行为意味着分析师对公司长期前景的评估比过去更加悲观。\n\n作为一家专注于免疫治疗药物研发的生物科技公司,ImmunityBio的前景存在较大的不确定性。分析师下调目标价可能使投资者对公司长期增长前景失去信心,从而抛售股票,导致股价大跌。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX"],"gpt_icon":0},{"id":"2460302706","title":"美国研究综述-欧特克、Crowdstrike、奥什科什","url":"https://stock-news.laohu8.com/highlight/detail?id=2460302706","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460302706?lang=zh_cn&edition=full","pubTime":"2024-08-19 15:20","pubTimestamp":1724052029,"startTime":"0","endTime":"0","summary":" 路透8月19日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价,其中包括欧特克、Crowdstrike 和奥什科什。要闻 * 欧特克公司 :加拿大皇家银行将目标价从260美元上调至290美元 * Crowdstrike :加拿大皇家银行将目标价从380美元下调至345美元 * Oshkosh Corp :Evercore ISI将目标价从137美元下调至119美元 * Vitesse Energy :Gerdes Energy Research给予其中性评级 * Vontier Corp :Evercore ISI将目标价从45美元下调至40美元 以下是路透周一报导的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INVH","CAT","BRY","LU0054578231.USD","IE00B894F039.SGD","DRIO","BILL","AHH","ALB","CDNA","CVX","LU0612318385.USD","KEY","AMH","PCAR","BK4566","LAZR","NTR","LU0612318971.USD","ADSK","ESAB","DE","LU0050427557.USD","IR","MFA","CF","CMI","HIPO","OS","GTES","NTNX","IBRX","MUR","MOS","COLD","ITW","BASE","LU0368265418.SGD","LU0654597011.USD","OSK","LINE","MNPR","MPC","BK4551","CON","DINO","CRWD","BK4516","BK4550"],"gpt_icon":1},{"id":"2459039891","title":"Immunitybio, Inc.盘中异动 早盘股价大跌5.72%报3.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459039891","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459039891?lang=zh_cn&edition=full","pubTime":"2024-08-14 22:34","pubTimestamp":1723646091,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日22时34分,Immunitybio, Inc.股票出现异动,股价急速下挫5.72%。截至发稿,该股报3.55美元/股,成交量112.638万股,换手率0.16%,振幅5.58%。Immunitybio, Inc.股票所在的生物技术行业中,整体涨幅为0.03%。Immunitybio, Inc.公司简介:ImmunityBio Inc 是一家临床阶段的综合性生物技术公司,致力于发现,开发和商业化下一代免疫和细胞疗法,以增强天然免疫系统,驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081422345197198bb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081422345197198bb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"2459549904","title":"Immunitybio, Inc.盘中异动 早盘大幅下跌6.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459549904","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459549904?lang=zh_cn&edition=full","pubTime":"2024-08-13 21:59","pubTimestamp":1723557566,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日21时59分,Immunitybio, Inc.股票出现异动,股价快速跳水6.11%。Immunitybio, Inc.股票所在的生物技术行业中,整体涨幅为0.79%。Immunitybio, Inc.公司简介:ImmunityBio Inc 是一家临床阶段的综合性生物技术公司,致力于发现,开发和商业化下一代免疫和细胞疗法,以增强天然免疫系统,驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813215926aefe9f80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813215926aefe9f80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"2458909305","title":"Immunitybio, Inc.盘中异动 早盘急速拉升5.09%报4.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458909305","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458909305?lang=zh_cn&edition=full","pubTime":"2024-08-09 23:19","pubTimestamp":1723216792,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日23时19分,Immunitybio, Inc.股票出现异动,股价急速上涨5.09%。截至发稿,该股报4.57美元/股,成交量59.6488万股,换手率0.09%,振幅6.55%。Immunitybio, Inc.股票所在的生物技术行业中,整体涨幅为2.50%。Immunitybio, Inc.公司简介:ImmunityBio Inc 是一家临床阶段的综合性生物技术公司,致力于发现,开发和商业化下一代免疫和细胞疗法,以增强天然免疫系统,驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809231952941ffc3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809231952941ffc3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"2457038310","title":"Immunitybio, Inc.盘中异动 早盘大幅上涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457038310","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457038310?lang=zh_cn&edition=full","pubTime":"2024-08-08 22:55","pubTimestamp":1723128908,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日22时55分,Immunitybio, Inc.股票出现波动,股价急速上涨5.05%。Immunitybio, Inc.股票所在的生物技术行业中,整体涨幅为2.63%。Immunitybio, Inc.公司简介:ImmunityBio Inc 是一家临床阶段的综合性生物技术公司,致力于发现,开发和商业化下一代免疫和细胞疗法,以增强天然免疫系统,驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808225508af96a153&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808225508af96a153&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"2457026361","title":"Immunitybio, Inc.盘中异动 早盘快速拉升5.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457026361","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457026361?lang=zh_cn&edition=full","pubTime":"2024-08-06 21:48","pubTimestamp":1722952087,"startTime":"0","endTime":"0","summary":"北京时间2024年08月06日21时48分,Immunitybio, Inc.股票出现异动,股价大幅拉升5.68%。Immunitybio, Inc.股票所在的生物技术行业中,整体涨幅为0.90%。Immunitybio, Inc.公司简介:ImmunityBio Inc 是一家临床阶段的综合性生物技术公司,致力于发现,开发和商业化下一代免疫和细胞疗法,以增强天然免疫系统,驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806214807ab5d8636&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806214807ab5d8636&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2457731177","title":"Immunitybio, Inc.盘中异动 大幅下挫8.12%报4.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457731177","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457731177?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:39","pubTimestamp":1722865163,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时39分,Immunitybio, Inc.股票出现异动,股价快速下跌8.12%。截至发稿,该股报4.30美元/股,成交量61.4895万股,换手率0.09%,振幅4.70%。Immunitybio, Inc.股票所在的生物技术行业中,整体跌幅为2.30%。Immunitybio, Inc.公司简介:ImmunityBio Inc 是一家临床阶段的综合性生物技术公司,致力于发现,开发和商业化下一代免疫和细胞疗法,以增强天然免疫系统,驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213924957f32f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213924957f32f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immunitybio.com","stockEarnings":[{"period":"1week","weight":-0.1572},{"period":"1month","weight":0.516},{"period":"3month","weight":0.2093},{"period":"6month","weight":-0.3434},{"period":"1year","weight":0.3867},{"period":"ytd","weight":0.0359}],"compareEarnings":[{"period":"1week","weight":-0.019},{"period":"1month","weight":-0.0055},{"period":"3month","weight":0.0913},{"period":"6month","weight":0.1017},{"period":"1year","weight":0.3108},{"period":"ytd","weight":0.1988}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ImmunityBio, Inc.于2002年10月7日在伊利诺伊州ZelleRx Corporation公司的名义下注册成立,于2010年1月22日,公司更名为Conkwest股份有限公司。ImmunityBio是一家领先的后期免疫疗法公司,可激活先天性(NK细胞和巨噬细胞)和适应性(T细胞)免疫系统,以治疗肿瘤学和传染病中严重的未满足需求。他们是现成的自然杀伤(NK)细胞疗法,自体/同种异体记忆NK细胞(m-ceNK)的临床剂型的领先生产商,以及抗体细胞因子融合蛋白,白蛋白结合化学疗法的全面平台免疫调节剂和疫苗载体。通过组合这些NK,巨噬细胞和T细胞活化平台,他们相信ImmunityBio引领免疫疗法领域,跨多种肿瘤类型和感染性疾病进行后期临床开发。","yearOnYearQuotes":[{"month":1,"riseRate":0.222222,"avgChangeRate":-0.010395},{"month":2,"riseRate":0.555556,"avgChangeRate":0.03495},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.083743},{"month":4,"riseRate":0.555556,"avgChangeRate":0.042504},{"month":5,"riseRate":0.333333,"avgChangeRate":0.053418},{"month":6,"riseRate":0.333333,"avgChangeRate":0.147898},{"month":7,"riseRate":0.444444,"avgChangeRate":-0.024912},{"month":8,"riseRate":0.3,"avgChangeRate":-0.116269},{"month":9,"riseRate":0.3,"avgChangeRate":-0.041956},{"month":10,"riseRate":0.5,"avgChangeRate":0.035321},{"month":11,"riseRate":0.7,"avgChangeRate":0.138791},{"month":12,"riseRate":0.444444,"avgChangeRate":0.132393}],"exchange":"NASDAQ","name":"ImmunityBio, Inc.","nameEN":"ImmunityBio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ImmunityBio, Inc.(IBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ImmunityBio, Inc.(IBRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ImmunityBio, Inc.,IBRX,ImmunityBio, Inc.股票,ImmunityBio, Inc.股票老虎,ImmunityBio, Inc.股票老虎国际,ImmunityBio, Inc.行情,ImmunityBio, Inc.股票行情,ImmunityBio, Inc.股价,ImmunityBio, Inc.股市,ImmunityBio, Inc.股票价格,ImmunityBio, Inc.股票交易,ImmunityBio, Inc.股票购买,ImmunityBio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ImmunityBio, Inc.(IBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ImmunityBio, Inc.(IBRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}